HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

TLRY

Tilray Brands, Inc. (NASDAQ)

Healthcare — Drug Manufacturers - Specialty & Generic

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Cruisies, Atwater Brewery, Hiball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin Beer Co., Happy Flower, Fizzy Jane's, Herb & Bloom, 420 Fizz, and Fresh Hemp Foods brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Buy 2.5 / 5 9 analysts
$4.59
+$0.16 (+3.50%)
Target: $9.41 (105.1%)
Sign in to add TLRY to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$566.05M
P/E Ratio (TTM)-
Forward P/E16.91
EPS (TTM)$-14.63
Dividend Yield-
Profit Margin-156.66%
Revenue Growth-7.80%
ROE-63.16%
Debt/Equity63.61
Recommendation Buy 2.5
Analyst Target$9.41
Analysts9
Indexes NASDAQ

Technical Indicators

RSI (14)29.5
Beta1.88
SMA 20-
SMA 40-
52-Week High$23.20
52-Week Low$4.28
50-Day Avg$5.44
200-Day Avg$8.86
Avg Volume$4.85M
Volume242.0K

Performance Analysis

NEUTRAL

TLRY presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($4.28), which could present a value opportunity.
+ RSI at 29.5 signals oversold conditions — a bounce may be ahead.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 7.8% year-over-year.
- Operating at a loss with -156.7% margin.
+ Wall Street consensus is "Buy" from 9 analysts.
+ Average analyst target of $9.41 implies 105.1% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:34 UTC

Back to Screener Export Report